Shorepower Technologies to Rebrand as Aeternum Health, Authorizes Massive Share Increase for Business Pivot

summarizeZusammenfassung

This PRE 14C filing details the corporate actions necessary to implement the strategic pivot announced in the 8-K filed on 2026-02-23. The name change to Aeternum Health Inc. signifies a complete transformation of the company's business focus. Concurrently, the substantial increase in authorized common stock from 100 million to 250 million shares provides the company with significant flexibility for future capital raises, potential mergers, or other corporate transactions related to its new health-focused venture. While this authorization is crucial for the new business direction, it also introduces the potential for substantial dilution for existing shareholders if all authorized shares were to be issued, representing over 300% potential dilution relative to current outstanding shares. The approval by a majority shareholder, Jeff Kim, who controls 83% of voting stock, ensures these changes will proceed.

check_boxSchlusselereignisse

• Company Name Change Approved

  Shareholders approved changing the company's name from Shorepower Technologies, Inc. to Aeternum Health Inc., reflecting a new focus on developing health and longevity solutions. This follows the 8-K filed on 2026-02-23 announcing a merger with Aeternum Health LLC and a business pivot.

• Authorized Shares Significantly Increased

  The number of authorized common stock shares will increase from 100,000,000 to 250,000,000. With 59,290,204 shares currently outstanding, this authorization provides headroom for over 300% potential dilution if all shares were issued, offering substantial flexibility for future capital raises or strategic transactions related to the new business.

• Majority Shareholder Approval

  These proposals were approved by written consent of shareholders holding approximately 52% of the voting power, with President and CEO Jeff Kim controlling 83% of the voting stock, ensuring the corporate actions will be implemented.

auto_awesomeAnalyse

This PRE 14C filing details the corporate actions necessary to implement the strategic pivot announced in the 8-K filed on 2026-02-23. The name change to Aeternum Health Inc. signifies a complete transformation of the company's business focus. Concurrently, the substantial increase in authorized common stock from 100 million to 250 million shares provides the company with significant flexibility for future capital raises, potential mergers, or other corporate transactions related to its new health-focused venture. While this authorization is crucial for the new business direction, it also introduces the potential for substantial dilution for existing shareholders if all authorized shares were to be issued, representing over 300% potential dilution relative to current outstanding shares. The approval by a majority shareholder, Jeff Kim, who controls 83% of voting stock, ensures these changes will proceed.